All participants will be given an insulin pump that can receive and display CGM data (Mini-Med Paradigm Veo insulin pump) and will be taught how to use the on-board bolus calculator.
Children were given an individualized insulin dose, and postprandial glucose was examined for 5 h after administration of the test meals to understand both the short- and long-term impact of the nutrient content.
To study direct effects of insulin on the LPL system, fasted rats were given an intraperitoneal injection of insulin, 1 U/kg body weight, which is in the range used for insulin tolerance tests in rodents [ 26].
The subjects were given an intravenous infusion of insulin (Humalog; Eli Lilly) at a continuous rate of 80 mU/m/min, with doubling of the rate for the first 5 min. Plasma glucose was measured bedside at 5-min intervals and the glucose infusion rate (20% dextrose in saline) adjusted to achieve the target plasma glucose concentration.
Just after diagnosis, individuals were given a subcutaneous insulin implant, which lowers blood-glucose levels to the normal range within 2 days, where they remain for only about 7 days in the absence of further insulin supplementation.
For hyperinsulinemic-euglycemic clamp experiments, rats were given a primed, continuous insulin infusion (as above) for two hrs.
Liraglutide 1.8 mg/day was continued, and on day 36 subjects were given a single dose of insulin detemir (0.5 units/kg) in addition to lirgalutide, and a third euglycemic clamp was performed.
In one randomized, double-blind, crossover study, 19 elderly (≥65 years) subjects with uncomplicated T2D were given a single injection of insulin aspart or RHI during a euglycemic clamp [ 59].
Others were given a synthesized gene for insulin-like growth factor 1, which was designed to improve their digestion.
Note: While I was given a Timesulin insulin cap at the IDF World Congress in Dubai, in full disclosure I have no commercial ties with Timesulin, nor have I been asked to write this, or any other article, for them.
